TheEdgeResearch
Home / Stocks / REZNF

Street Capital Inc. (REZNF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$56,090
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.69
52-Wk Range
0.0002-0.01185
CEO
Chris Savoie
Country
CA
Currency
USD

Street Capital Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $56,090. On trailing twelve-month figures it carries a trailing P/E of -3.33, a net margin of -75.8%. Its beta of 0.69 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-3.33
Price / Sales
2.53
Price / Book
-3.54
EV / EBITDA
-6.19
Gross margin
57.4%
Operating margin
-48.0%
Net margin
-75.8%
Return on equity
Debt / equity
-0.68
Current ratio
0.36
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
72
IPO date
2021-09-24
Headquarters
Toronto, ON, CA
About Street Capital Inc.

A detailed company description for Street Capital Inc. has not been supplied.

Comparable companies

Street Capital Inc. is most often compared with the following Healthcare names:

BBBTCANLEAPHGCANGREHINLBLRDSFMOBOTRCNFWRHLF
More research on REZNF
REZNF technical analysis REZNF TheEdge Score Compare against peers
Open full interactive analysis & DCF →